| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.005 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.16 | 0.005 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.095 | 0.007 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.09 | 0.007 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.008 |